Similar articles

• Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.

  Mulder LC, Mora M, Lazzeri M, Boschi M, Ciccopiedi E, Melli C, Bruzzone P, Alfani D. Mulder LC, et al. Transplant Proc. 1996 Apr;28(2):589. Transplant Proc. 1996. PMID: 8623287 No abstract available.
• Mice transgenic for human CD46 and CD55 are protected from human complement attack.

  Mulder LC, Mora M, Ciccopiedi E, Melli C, Nuti S, Marinucci G, Bruzzone P, Lazzeri M, Lorenzini R, Alfani D, et al. Mulder LC, et al. Transplant Proc. 1995 Feb;27(1):333-5. Transplant Proc. 1995. PMID: 7533403 No abstract available.
• High-level tissue specific expression of human CD59, MCP, and DAF proteins from genomic clones in transgenic mice.

  Oldham ER, Velardo MA, Platt JL, Logan JS, Diamond L. Oldham ER, et al. Transplant Proc. 1996 Apr;28(2):693. Transplant Proc. 1996. PMID: 8623349 No abstract available.
• [Complement regulatory factors and immunologic recognition mechanism between species].

  Seya T, Matsunoto M. Seya T, et al. Nihon Rinsho Meneki Gakkai Kaishi. 1995 Dec;18(6):637-42. Nihon Rinsho Meneki Gakkai Kaishi. 1995. PMID: 8963770 Review. Japanese. No abstract available.
• Complement regulatory molecules: application to therapy and transplantation.

  Morgan BP. Morgan BP. Immunol Today. 1995 Jun;16(6):257-9. doi: 10.1016/0167-5699(95)80175-8. Immunol Today. 1995. PMID: 7544975 Review. No abstract available.